Advanced Enzyme Technologies Limited has informed the Exchange that Board of Directors at its meeting held on May 13, 2025, declared Interim Dividend of Rs. 4 per equity share.

Corporate Actions View source PDF Explain this filing

ADVENZYMES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.5%Reaction day

₹296.50

prior close

₹296.30

announcement price

In-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+1.6%-4.1% vs market

Pharmaceuticals & Biotechnology peers, median of 152sector · industry level+0.9%-3.4% vs sector

On the reaction day the stock moved 4.1 pts less than Nifty Microcap 250 and 3.4 pts less than its Pharmaceuticals & Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-1.6

15m

-1.8

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.5+1.6-4.1+0.9-3.4

Next day

-3.2+3.3-6.5+2.0-5.2

-1.5+4.3-5.8+2.4-3.9

-2.2+5.1-7.3+3.2-5.4

-1.0+6.4-7.4+3.7-4.7

-2.4+5.2-7.6+3.5-5.8

-2.5+5.9-8.5+3.6-6.1

15d

+2.9+8.0-5.1+3.9-1.0

+8.3+9.8-1.5+5.5+2.7

+8.6+11.8-3.2+7.0+1.6

+3.9+7.2-3.3+2.9+1.0

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals & Biotechnology peers, median of 152Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board of Directors of Advanced Enzyme Technologies Limited, at its meeting held on May 13, 2025, declared an Interim Dividend of Rs. 4 per equity share (200% on face value of Rs. 2) for FY 2025-26, with a record date of May 17, 2025 and payment on or before June 10, 2025. It also recommended a Final Dividend of Rs. 1.20 per share (60%) for FY 2024-25, subject to shareholder approval at the 36th AGM on July 30, 2025, with a record date of July 23, 2025 — taking total dividends for the year to Rs. 5.20 per share. The Board approved audited consolidated FY25 results showing total income of Rs. 6,699.51 million (vs Rs. 6,605.32 million in FY24) and net profit of Rs. 1,339.74 million (vs Rs. 1,369.51 million), a marginal dip of about 2% YoY. EPS stood at Rs. 11.72 (basic). Additionally, the Board approved the incorporation of a new wholly-owned subsidiary in India and appointed Mr. Shiv Hari Jalan as Secretarial Auditor for five years. Statutory auditor MSKA & Associates issued an unmodified opinion on the financials.

Likely market impact

Shareholders get a healthy total dividend payout of Rs. 5.20 per share, with the interim dividend payable quickly by June 2025, which is supportive for income-focused investors. However, the marginal decline in net profit and broadly flat revenue growth may limit upside momentum in the stock; the new subsidiary signals management's expansion intent but adds execution risk.